LexaGene (LXG) News Today C$0.10 -0.03 (-19.23%) (As of 02/21/2023) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period April 9, 2024 | lse.co.ukPamapol Ord Share Price (0LXG)November 12, 2023 | morningstar.comBiosynex SA ALBIOOctober 31, 2023 | morningstar.comCyclopharm Ltd CYCOctober 16, 2023 | investing.comLexagene Holdings Inc (LXGh)September 2, 2023 | morningstar.comEurobio Scientific Bearer and/or Registered shares issued from reverse spliJuly 28, 2023 | morningstar.comZhejiang Gongdong Medical Technology Co Ltd Class AFebruary 22, 2023 | finance.yahoo.comIIROC Trading Halt - LXGOctober 20, 2022 | marketscreener.comLexaGene Says Large Biopharma Co Engages It in Statement of Work to Expedite Technology Validation - Marketscreener.comOctober 20, 2022 | globenewswire.comLarge Biopharma Company Engages LexaGene in Statement of Work to Expedite Technology Validation - GlobeNewswireOctober 19, 2022 | streetinsider.comForm 10-Q LexaGene Holdings Inc. For: Aug 31 - StreetInsider.comOctober 13, 2022 | marketscreener.comLexaGene Rises 23% as Says Got Signed Quote from Large Biopharma Company to Buy a MiQLab System - Marketscreener.comOctober 13, 2022 | marketscreener.comLexaGene Says Received Signed Quote from Large Biopharma Company to Buy a MiQLab System - Marketscreener.comOctober 13, 2022 | globenewswire.comLexaGene Receives Signed Quote from Large Biopharma Company to Purchase a MiQLab System - GlobeNewswireOctober 4, 2022 | businesswire.comVeterinary Infectious Disease Diagnostics Global Market Report 2022: Increasing Incidence of Transboundary and Zoonotic Diseases Drives Growth - ResearchAndMarkets.com - Business WireSeptember 1, 2022 | financialpost.comLexaGene Announces MiQLab® System Sale to Veterinary Hospital in California - Financial PostSeptember 1, 2022 | gurufocus.comLexaGene Announces MiQLab® Sys - GuruFocus.comSeptember 1, 2022 | benzinga.comLEXAGENE HLDGS INC ORD by Lexagene Hldgs Inc. (LXXGF), (TSXV:LXG) – LexaGene Announces MiQLab® System Sal - BenzingaAugust 29, 2022 | globenewswire.comLexaGene Verifies CDC Monkeypox Assay Works on MiQLab System and Readies Company Should an EUA be Declared - GlobeNewswireAugust 24, 2022 | globenewswire.comLexaGene's MiQLab System Generates Leptospira Results in as - GlobeNewswireAugust 23, 2022 | marketscreener.comLexaGene : OTCQB Cert - Marketscreener.comAugust 17, 2022 | marketscreener.comLexaGene Says U of Penn's School of Veterinary Medicine to Evaluate New Gastrointestinal Panel With MiQLab System - Marketscreener.comAugust 17, 2022 | globenewswire.comUniversity of Pennsylvania's School of Veterinary Medicine - GlobeNewswireAugust 10, 2022 | globenewswire.comLexaGene Reduces Time-to-Result by ~35% - GlobeNewswireAugust 9, 2022 | streetinsider.comForm 10-12G/A LexaGene Holdings Inc. - StreetInsider.comAugust 3, 2022 | finance.yahoo.comRising Transboundary And Zoonotic Disease Cases Are Fueling The Growth Of The Veterinary Infectious Disease Diagnostics Market As Per The Business Research Company's Veterinary Infectious Disease Diagnostics Global Market Report 2022 - Yahoo FinanceAugust 3, 2022 | globenewswire.comRising Transboundary And Zoonotic Disease Cases Are Fueling The Growth Of The Veterinary Infectious Disease Diagnostics Market As Per The Business Research Company's Veterinary Infectious Disease Diagnostics Global Market Report 2022 - GlobeNewswireJuly 29, 2022 | globenewswire.comLexaGene Announces Filing of Financial Statements, Revocation of MCTO & the Granting of Incentive Equity Awards to Employees - GlobeNewswireJuly 27, 2022 | marketscreener.comLexaGene Holdings Completes Multi-Center Validation Study Using MiQLab System for Diagnosing Urinary Tract Infections - Marketscreener.comJuly 27, 2022 | finance.yahoo.comGlobal COVID-19 Diagnostics Market Research Report 2022: Focus on PCR, PCR Multiplex, Sequencing, Antibody, & Antigens - Yahoo FinanceJuly 27, 2022 | benzinga.comGlobal COVID-19 Diagnostics Market Research Report 2022: Focus on PCR, PCR Multiplex, Sequencing, Antibod - BenzingaJuly 27, 2022 | globenewswire.comLexaGene Completes Multi-Center Validation Study Using MiQLab® System for Diagnosing Urinary Tract Infections - GlobeNewswireJuly 23, 2022 | finance.yahoo.comGlobal PCR Market Outlook Report 2022: The Instrumentation Curve, Shifting Role of Diagnostics, Diagnostics Moves Out of the Hospital, Disruption Looms, The Next Five Years - Yahoo FinanceJuly 12, 2022 | globenewswire.comLexaGene Provides MCTO Update - GlobeNewswireJuly 8, 2022 | gurufocus.comLexaGene Files Form 10 Registr - GuruFocus.comJuly 5, 2022 | globenewswire.comLexaGene Announces Webinar by UC Davis Professor on Use of MiQLab® System for Diagnosis of Urinary Tract Infections - GlobeNewswireJuly 1, 2022 | proactiveinvestors.comUS benchmarks ride afternoon rally into 4th of July weekend - Proactive Investors USAJuly 1, 2022 | ca.proactiveinvestors.comNA Proactive news snapshot: Naturally Splendid Enterprises, Aion Therapeutic, GoviEx Uranium, Kovo HealthTech ... - Proactive Investors CanadaJuly 1, 2022 | proactiveinvestors.comNA Proactive news snapshot: Rio2 Limited, Nevada Copper, Naturally Splendid Enterprises, Aion Therapeutic, GoviEx Uranium UPDATE... - Proactive Investors USAJuly 1, 2022 | proactiveinvestors.comUS benchmarks start lower as traders await latest economic data - Proactive Investors USAJuly 1, 2022 | financialpost.comProactive news headlines including Kohl's, SpaceX, Hillcrest Energy Technologies, Naturally Splendid Enterprises and Aion Therapeutic - Financial PostJuly 1, 2022 | gurufocus.comLexaGene Announces MiQLab® System Sale to Veterinary Hospital in Wisconsin - GuruFocus.comJuly 1, 2022 | proactiveinvestors.comLexaGene Holdings announces MiQLab Systems sale to veterinary hospital in Wisconsin - Proactive Investors USAJune 30, 2022 | gurufocus.comLexaGene Announces Management Cease Trade Order - GuruFocus.comJune 30, 2022 | stockhouse.com2022-06-30 | TSXV:LXG | Press Release | Lexagene Holdings Inc - StockhouseJune 29, 2022 | finance.yahoo.comLexaGene Files Form 10 Registration Statement with the SEC and Announces a Delay in Filing Year-End Annual Canadian Financial Filings - Yahoo FinanceJune 29, 2022 | marketscreener.comLexaGene Holdings Reports Delay In Filing Year-End Financial Report - Marketscreener.comJune 28, 2022 | globenewswire.comLexaGene Files Form 10 Registration Statement with the SEC and Announces a Delay in Filing Year-End Annual Canadian Financial Filings - GlobeNewswireJune 24, 2022 | gurufocus.comLexaGene Announces Multi-System Purchase from a Large Market Leader in Animal Health - GuruFocus.comMay 25, 2022 | proactiveinvestors.comNA Proactive news snapshot: Jushi Holdings, Evergen Infrastructure, Vox Royalty, Ready Set Gold ... - Proactive Investors USAMay 25, 2022 | globenewswire.comLexaGene Announces Multi-System Purchase from a Large Market Leader in Animal Health - GlobeNewswire Get LexaGene News Delivered to You Automatically Sign up to receive the latest news and ratings for LXG and its competitors with MarketBeat's FREE daily newsletter. Email Address This TSLA short trade is on a nine win hot streak (Ad)Most Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself. But I can promise that you’ll see all the details for yourself here. LXG Media Mentions By Week LXG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LXG News Sentiment▼0.000.62▲Average Medical News Sentiment LXG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LXG Articles This Week▼00▲LXG Articles Average Week Get LexaGene News Delivered to You Automatically Sign up to receive the latest news and ratings for LXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AKU News EDT News COV News PMN News KDA News DMT News MBX News RHT News TLT News CWEB News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:LXG) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LexaGene Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LexaGene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.